- CA$259.21m
- CA$273.46m
- CA$65.51m
- 80
- 12
- 73
- 54
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 15 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 37.6 | 38.1 | 38.7 | 69 | 65.5 |
Cost of Revenue | |||||
Gross Profit | 28.5 | 28.1 | 28 | 43.6 | 39.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24.1 | 35.6 | 32.4 | 66.1 | 64 |
Operating Profit | 13.5 | 2.47 | 6.28 | 2.95 | 1.54 |
Net Income Before Taxes | 13.5 | 2.47 | 6.28 | 2.95 | 1.54 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10 | 1.92 | 4.37 | 2.54 | 1.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 10 | 1.92 | 4.37 | 2.54 | 1.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10 | 1.92 | 4.37 | 2.54 | 1.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.446 | 0.104 | 0.213 | 0.128 | 0.047 |
Dividends per Share |